Therefore, the GC patients with high MGP expression may be sensitive to STAT5 inhibitor treatment, which provided a potential precision medicine strategy by using STAT5 inhibitor combined with other chemotherapy in MGP‐high GC patients. The gene discussed is MGP; the disease is gastric cancer.